Kristin Wesnes

ORCID: 0000-0002-0918-8367
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Multiple Sclerosis Research Studies
  • Cancer-related cognitive impairment studies
  • Treatment of Major Depression
  • Pharmacological Effects and Toxicity Studies
  • Systemic Sclerosis and Related Diseases
  • Immunotherapy and Immune Responses
  • Advanced MRI Techniques and Applications
  • Skin and Cellular Biology Research
  • Chronic Lymphocytic Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Effects of Vibration on Health
  • Poisoning and overdose treatments
  • Acute Lymphoblastic Leukemia research
  • Celiac Disease Research and Management
  • Reproductive System and Pregnancy
  • Powdery Mildew Fungal Diseases
  • Psoriasis: Treatment and Pathogenesis
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Historical Studies on Reproduction, Gender, Health, and Societal Changes
  • Systemic Lupus Erythematosus Research
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Healthcare Systems and Challenges
  • Epilepsy research and treatment
  • Feminism, Gender, and Sexuality Studies
  • Stress Responses and Cortisol

Haukeland University Hospital
2014-2025

St Olav's University Hospital
2015-2022

University of Bergen
2013-2022

Mane (France)
2016

United BioSource Corporation (United Kingdom)
2011

Rochester Institute of Technology
2007

University of Rochester
2007

Background: Obesity may be a risk factor for developing multiple sclerosis (MS). Objective: We examined if body size influences the of MS in population-based, case control study. Methods: A total 953 cases and 1717 controls from Norway 707 1333 Italy reported their by choosing silhouette 1 to 9 (largest) every fifth year age 5 30 at time The size-related was defined odds ratios (ORs) logistic regression analyses adjusting age, smoking outdoor activity. Results: In large (silhouettes 6–9)...

10.1177/1352458514546785 article EN Multiple Sclerosis Journal 2014-09-02

Objectives: The objective of this paper is to estimate the association between multiple sclerosis (MS) and measures sun exposure in specific age periods Norway Italy. Methods: A total 1660 MS patients 3050 controls from Italy who participated a multinational case-control study (EnvIMS) reported habits during childhood adolescence. Results: significant infrequent summer outdoor activity increased risk was found strongest ages 16 18 years (odds ratio (OR) 1.83, 95% confidence interval (CI)...

10.1177/1352458513513968 article EN Multiple Sclerosis Journal 2014-01-10

Background: The lifestyle factors smoking and obesity have been associated with the risk of multiple sclerosis (MS). Physical activity (PA) may also be importance. Objective: To examine association between PA MS in Italy, Norway, Sweden to evaluate possible influence by established factors. Methods: In this case–control study, 1904 cases 3694 controls were asked report their average weekly amounts light vigorous during adolescence on a scale ranging from none more than 3 hours activity. We...

10.1177/1352458517694088 article EN Multiple Sclerosis Journal 2017-02-01

The underlying mechanisms for neurodegeneration in multiple sclerosis are complex and incompletely understood. Multivariate multimodal investigations integrating demographic, clinical, multi-omics, neuroimaging data provide opportunities nuanced analyses, aimed to define disease progression markers. We used from a 12-year longitudinal cohort of 88 people with sclerosis, test the predictive value MRI, clinical examinations, self-reports on quality life, demographics, general health-related...

10.1101/2025.02.09.25321961 preprint EN cc-by medRxiv (Cold Spring Harbor Laboratory) 2025-02-12

Background: Seasonal fluctuations in solar radiation and vitamin D levels could modulate the immune response against Epstein-Barr virus (EBV) infection influence subsequent risk of multiple sclerosis (MS). Methods: Altogether 1660 MS patients 3050 controls from Norway Italy participating multinational case-control study Environmental Factors In Multiple Sclerosis (EnvIMS) reported season past infectious mononucleosis (IM). Results: IM was generally more frequently ( p=0.002), but associated...

10.1177/1352458513505693 article EN Multiple Sclerosis Journal 2013-09-26

Abstract Objective To determine whether reliable brain atrophy measures can be obtained from post-contrast 3D T1-weighted images in patients with multiple sclerosis (MS) using FreeSurfer. Methods Twenty-two MS were included, which MR during the same scanner visit, acquisition protocol, before and after administration of gadolinium-based contrast agents (GBCAs). Two FreeSurfer versions (v.6.0.1 v.7.1.1.) applied to calculate grey matter (GM) white (WM) volumes global regional cortical...

10.1007/s00330-021-08405-8 article EN cc-by European Radiology 2022-01-03

Background The predictive value of serum neurofilament light chain (sNfL) on long-term prognosis in multiple sclerosis (MS) is still unclear. Objective Investigate the relation between sNfL levels over a 2-year period patients with relapsing-remitting MS, and clinical disability grey matter (GM) atrophy after 10 years. Methods 85 patients, originally enrolled multicentre, randomised trial ω−3 fatty acids, participated 10-year follow-up visit. were measured by Simoa quarterly until month 12,...

10.1136/jnnp-2021-328568 article EN cc-by Journal of Neurology Neurosurgery & Psychiatry 2022-06-01

<h3>Background and Objectives</h3> The relationship between smoking, long-term brain atrophy, clinical disability in patients with multiple sclerosis (MS) is unclear. Here, we assessed effects of smoking by evaluating MRI outcome measures after 10 years nonsmoking relapsing-remitting MS (RRMS). <h3>Methods</h3> We included 85 treatment-naive RRMS recent inflammatory disease activity who participated a 10-year follow-up visit multicenter trial 24 months. Smoking status was decided for each...

10.1212/nxi.0000000000200008 article EN cc-by-nc-nd Neurology Neuroimmunology & Neuroinflammation 2022-06-23

9004 Background: Patients receiving treatment for cancer can experience a diminution of their cognitive abilities which persist many years after. The present study examined the potential modafinil as enhancer on memory and attention in randomized clinical trial breast patients following completion treatment. Methods: Breast who reported score = 2 Brief Fatigue Inventory (BFI) an average 22.8 months chemotherapy were enrolled. In Phase 1, received 200mg open-label once daily 4 weeks. 2, with...

10.1200/jco.2007.25.18_suppl.9004 article EN Journal of Clinical Oncology 2007-06-20

10.4045/tidsskr.16.0349 article NO cc-by-nd Tidsskrift for Den norske legeforening 2016-01-01

10.03.2015: Medisinen i bilder - En mann 20-årene med antatt posttraumatisk epilepsi etter en alvorlig hodeskade noen år tidligere ble innlagt lokalsykehus et epileptisk krampeanfall av minst 30 minutters varighet.

10.4045/tidsskr.14.1422 article NO cc-by-nd Tidsskrift for Den norske legeforening 2015-01-01
Coming Soon ...